✉ info@591daili.com☎ +86-18553102138
📞 WhatsApp中文
Home › Product Catalog › dacomitinib

dacomitinib

CAS 1110813-31-4C24H25ClFN5O2MW 469.9

dacomitinib (CAS 1110813-31-4) — formula C24H25ClFN5O2, molecular weight 469.9.

Product Overview

CAS Number1110813-31-4
Molecular FormulaC24H25ClFN5O2
Molecular Weight469.9
Melting Point184-187 ºC
Boiling Point665.7
LogP3.92

Technical Profile

What this product is

dacomitinib is a chemical compound with CAS registry number 1110813-31-4 and molecular formula C24H25ClFN5O2 (molecular weight 469.9).

Identification

CAS number: 1110813-31-4

Its molecular formula C24H25ClFN5O2 comprises 24 C, 25 H, 1 Cl, 1 F, 5 N, 2 O atoms.

Also known as: dacomitinib · 达克替尼

Frequently Asked Questions

What is the CAS number of dacomitinib?

The CAS registry number of dacomitinib is 1110813-31-4.

What is the molecular formula and molecular weight of dacomitinib?

Molecular formula C24H25ClFN5O2, molecular weight 469.9.

What other names is dacomitinib known by?

It is also registered under: dacomitinib, 达克替尼.

PubChem Public Data

Independent reference data for dacomitinib (CAS 1110813-31-4), compiled from public chemistry databases.

Registry identifiers across databases

CAS Registry Number1110813-31-4
PubChem CID11511120
Molecular formulaC24H25ClFN5O2
IUPAC name(E)-N-[4-(3-chloro-4-fluoroanilino)-7-methoxyquinazolin-6-yl]-4-piperidin-1-ylbut-2-enamide
UNII (FDA)2XJX250C20

Computed descriptors

Molecular Weight469.9
XLogP34.4
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count7
Rotatable Bond Count7
Exact Mass469.1680809
Monoisotopic Mass469.1680809
Topological Polar Surface Area79.4
Heavy Atom Count33

Physicochemical values on record

Boiling Point665.7
Melting Point184-187 ºC
Solubility<1 mg/mL
LogP3.92

Documented uses on record

    Dacomitinib is a multi-kinase receptor inhibitor used in the therapy of cases of non-small cell lung cancer that harbor activating mutations in the epidermal growth factor receptor gene (EGFR). Dacomitinib is associated with high rate of transient serum aminotransferase elevations during therapy but has not been linked to instances of clinically apparent acute liver injury.Breast Feeding; Lactation; Milk, Human; Antineoplastic Agents; Enzyme Inhibitors; Tyrosine Kinase Inhibitors

    Synonyms and trade names

    Dacomitinib; 1110813-31-4; PF-00299804; Dacomitinib anhydrous; dacomitinibum; Vizimpro; PF-299804; 2XJX250C20; pf00299804; PF 00299804-03; PF-00299804-03; (2e)-N-{4-[(3-Chloro-4-Fluorophenyl)amino]-7-Methoxyquinazolin-6-Yl}-4-(Piperidin-1-Yl)but-2-Enamide; CHEBI:132268; DTXSID50149493; (2E)-N-(4-((3-CHLORO-4-FLUOROPHENYL)AMINO)-7-METHOXYQUINAZOLIN-6-YL)-4-PIPERIDIN-1-YLBUT-2-ENAMIDE; 2-Butenamide, N-(4-((3-chloro-4-fluorophenyl)amino)-7-methoxy-6-quinazolinyl)-4-(1-piperidinyl)-, (2E)-

    What the public record says

    dacomitinib · CAS 1110813-31-4 · C24H25ClFN5O2. UNII 2XJX250C20. Boiling Point: 665.7; Melting Point: 184-187 ºC; Solubility: <1 mg/mL.

    Source: PubChem / Wikidata; the batch COA governs where values differ.

Request a Quote

✉ info@591daili.com☎ +86-18553102138📞 WhatsAppEmail InquiryWhatsApp Inquiry

Supplier: Jinan Shenghe Chemical Co., Ltd.

中文页面: 达克替尼

鲁ICP备19031700号-2